Tang Capital Management as of Dec. 31, 2019
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 17 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Odonate Therapeutics Ord | 54.6 | $457M | 14M | 32.45 | |
| Heron Therapeutics (HRTX) | 14.1 | $118M | 5.0M | 23.50 | |
| Rocket Pharmaceuticals (RCKT) | 8.1 | $68M | 3.0M | 22.76 | |
| Relmada Therapeutics (RLMD) | 6.1 | $51M | 1.3M | 39.00 | |
| Evolus (EOLS) | 3.8 | $32M | 2.6M | 12.17 | |
| Anaptysbio Inc Common (ANAB) | 3.6 | $30M | 1.8M | 16.25 | |
| Avrobio Ord (AVRO) | 2.4 | $20M | 1.0M | 20.13 | |
| La Jolla Pharmaceuticl Com Par | 2.3 | $19M | 4.9M | 3.93 | |
| Regeneron Pharmaceuticals (REGN) | 2.0 | $17M | 45k | 375.49 | |
| Bristol Myers Squibb (BMY) | 0.9 | $7.2M | 112k | 64.19 | |
| Prothena (PRTA) | 0.8 | $6.7M | 424k | 15.83 | |
| G1 Therapeutics (GTHX) | 0.5 | $4.5M | 170k | 26.43 | |
| Puma Biotechnology (PBYI) | 0.4 | $3.1M | 349k | 8.75 | |
| Iveric Bio | 0.3 | $2.1M | 250k | 8.58 | |
| Nucana Plc american depositary shares (NCNA) | 0.2 | $1.5M | 250k | 6.10 | |
| Rts/bristol-myers Squibb Compa | 0.0 | $337k | 112k | 3.01 | |
| Eidos Therapeutics | 0.0 | $217k | 3.8k | 57.36 |
